Status:
COMPLETED
Vouchers to Promote Tdap Vaccination
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
Robert Wood Johnson Foundation
University of Pennsylvania
Conditions:
Whooping Cough
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This study is a small-scale randomized, placebo-controlled factorial trial of two interventions to increase Tetanus, diphtheria and acellular pertussis (Tdap) immunization rates among infant caregiver...
Detailed Description
The incidence of pertussis, a highly contagious respiratory illness, has more than tripled in the past five years, and is on track this year to be the most severe in over a half century. Pertussis is ...
Eligibility Criteria
Inclusion
- All caregivers who report that they have never received Tdap
- Mothers who did not receive Tdap during their most recent pregnancy or since the birth of the child, even if she received Tdap during a previous pregnancy, as Tdap is now recommended for all pregnant women during each pregnancy.
- Previous receipt of a tetanus containing vaccine (i.e. Td or TT), regardless of the time interval since receipt of the tetanus-containing vaccine will be also eligible for the study.
- If a participant is certain they have not received Tdap within the past year but uncertain whether he/she has ever received Tdap, we will offer enrollment and encourage participants to obtain immunization records to confirm their status before voucher redemption. Rite Aid will follow their screening procedures which also includes assessing immunization status. Participants who do not know their Tdap vaccination status will receive the voucher intervention.
Exclusion
- Any adult caregiver who has previously received Tdap
- For recently-pregnant women: If a mother who received Tdap during her most recent pregnancy (2nd trimester or 3rd trimester) or since the birth of the child. Also, if the mother is unsure of her vaccination status and possibly received the vaccine during this pregnancy or in the last year
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT01860378
Start Date
July 1 2013
End Date
March 1 2015
Last Update
April 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karabots Primary Care Center - The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19139